Unresolved disorder model. using A ATOM 262 N AASP 34 -9.594 -10.343 31.974 0.50 16.01 N Unresolved disorder model. using A ATOM 263 CA AASP 34 -9.864 -11.440 32.907 0.50 16.56 C Unresolved disorder model. using A ATOM 264 C AASP 34 -11.275 -11.241 33.480 0.50 16.93 C Unresolved disorder model. using A ATOM 265 O AASP 34 -11.469 -10.391 34.349 0.50 17.43 O Unresolved disorder model. using A ATOM 266 CB AASP 34 -8.773 -11.446 33.985 0.50 16.80 C Unresolved disorder model. using A ATOM 267 CG AASP 34 -8.950 -12.558 35.008 0.50 18.53 C Unresolved disorder model. using A ATOM 268 OD1AASP 34 -8.938 -13.756 34.633 0.50 22.41 O Unresolved disorder model. using A ATOM 269 OD2AASP 34 -9.065 -12.214 36.202 0.50 23.40 O Unresolved disorder model. using A ATOM 270 N BASP 34 -9.546 -10.352 31.971 0.50 15.63 N Unresolved disorder model. using A ATOM 271 CA BASP 34 -9.911 -11.395 32.942 0.50 16.27 C Unresolved disorder model. using A ATOM 272 C BASP 34 -11.338 -11.135 33.384 0.50 16.84 C Unresolved disorder model. using A ATOM 273 O BASP 34 -11.615 -10.132 34.059 0.50 16.98 O Unresolved disorder model. using A ATOM 274 CB BASP 34 -8.977 -11.397 34.156 0.50 16.45 C Unresolved disorder model. using A ATOM 275 CG BASP 34 -9.330 -12.502 35.166 0.50 17.00 C Unresolved disorder model. using A ATOM 276 OD1BASP 34 -10.536 -12.791 35.350 0.50 15.14 O Unresolved disorder model. using A ATOM 277 OD2BASP 34 -8.391 -13.087 35.760 0.50 20.26 O Unresolved disorder model. using A ATOM 394 N ASER 50 -24.342 6.407 17.840 0.50 20.48 N Unresolved disorder model. using A ATOM 395 CA ASER 50 -25.254 7.186 16.997 0.50 20.85 C Unresolved disorder model. using A ATOM 396 C ASER 50 -24.688 7.340 15.600 0.50 20.40 C Unresolved disorder model. using A ATOM 397 O ASER 50 -23.977 8.300 15.313 0.50 19.91 O Unresolved disorder model. using A ATOM 398 CB ASER 50 -25.549 8.555 17.627 0.50 21.21 C Unresolved disorder model. using A ATOM 399 OG ASER 50 -26.299 8.397 18.825 0.50 22.69 O Unresolved disorder model. using A ATOM 400 N BSER 50 -24.300 6.379 17.813 0.50 20.27 N Unresolved disorder model. using A ATOM 401 CA BSER 50 -25.193 7.188 17.001 0.50 20.49 C Unresolved disorder model. using A ATOM 402 C BSER 50 -24.660 7.332 15.594 0.50 20.24 C Unresolved disorder model. using A ATOM 403 O BSER 50 -23.950 8.287 15.289 0.50 19.73 O Unresolved disorder model. using A ATOM 404 CB BSER 50 -25.387 8.561 17.633 0.50 20.76 C Unresolved disorder model. using A ATOM 405 OG BSER 50 -26.289 9.305 16.858 0.50 20.24 O Unresolved disorder model. using A ATOM 421 CA AASP 52 -27.673 7.126 11.555 0.45 23.23 C Unresolved disorder model. using A ATOM 422 CB AASP 52 -29.063 7.516 12.106 0.45 24.15 C Unresolved disorder model. using A ATOM 423 CG AASP 52 -29.103 8.906 12.734 0.45 24.92 C Unresolved disorder model. using A ATOM 424 OD1AASP 52 -28.074 9.610 12.731 0.45 28.77 O Unresolved disorder model. using A ATOM 425 OD2AASP 52 -30.183 9.290 13.251 0.45 27.61 O Unresolved disorder model. using A ATOM 426 CA BASP 52 -27.697 7.203 11.586 0.55 23.11 C Unresolved disorder model. using A ATOM 427 CB BASP 52 -28.903 7.919 12.185 0.55 23.93 C Unresolved disorder model. using A ATOM 428 CG BASP 52 -30.017 8.121 11.169 0.55 23.91 C Unresolved disorder model. using A ATOM 429 OD1BASP 52 -30.622 7.106 10.746 0.55 27.44 O Unresolved disorder model. using A ATOM 430 OD2BASP 52 -30.272 9.293 10.786 0.55 25.52 O Unresolved disorder model. using A ATOM 513 N AHIS 64 -0.723 -2.300 6.408 0.50 12.85 N Unresolved disorder model. using A ATOM 514 CA AHIS 64 -0.815 -3.027 7.681 0.50 12.60 C Unresolved disorder model. using A ATOM 515 C AHIS 64 -2.243 -3.411 8.084 0.50 12.37 C Unresolved disorder model. using A ATOM 516 O AHIS 64 -2.436 -4.174 9.046 0.50 11.31 O Unresolved disorder model. using A ATOM 517 CB AHIS 64 -0.138 -2.264 8.813 0.50 13.36 C Unresolved disorder model. using A ATOM 518 CG AHIS 64 -0.765 -0.937 9.149 0.50 13.14 C Unresolved disorder model. using A ATOM 519 ND1AHIS 64 -0.240 0.257 8.712 0.50 14.43 N Unresolved disorder model. using A ATOM 520 CD2AHIS 64 -1.835 -0.618 9.916 0.50 13.99 C Unresolved disorder model. using A ATOM 521 CE1AHIS 64 -0.956 1.256 9.198 0.50 14.06 C Unresolved disorder model. using A ATOM 522 NE2AHIS 64 -1.929 0.751 9.935 0.50 13.07 N Unresolved disorder model. using A ATOM 523 N BHIS 64 -0.734 -2.315 6.392 0.50 13.01 N Unresolved disorder model. using A ATOM 524 CA BHIS 64 -0.819 -3.005 7.676 0.50 12.80 C Unresolved disorder model. using A ATOM 525 C BHIS 64 -2.223 -3.609 7.825 0.50 12.99 C Unresolved disorder model. using A ATOM 526 O BHIS 64 -2.393 -4.764 8.272 0.50 12.98 O Unresolved disorder model. using A ATOM 527 CB BHIS 64 -0.513 -2.035 8.809 0.50 13.49 C Unresolved disorder model. using A ATOM 528 CG BHIS 64 0.702 -1.185 8.563 0.50 12.70 C Unresolved disorder model. using A ATOM 529 ND1BHIS 64 1.985 -1.683 8.634 0.50 12.61 N Unresolved disorder model. using A ATOM 530 CD2BHIS 64 0.826 0.126 8.250 0.50 11.96 C Unresolved disorder model. using A ATOM 531 CE1BHIS 64 2.848 -0.711 8.392 0.50 14.12 C Unresolved disorder model. using A ATOM 532 NE2BHIS 64 2.168 0.394 8.140 0.50 13.54 N Unresolved disorder model. using A ATOM 655 CA ALYS 80 -21.039 9.174 23.584 0.45 17.03 C Unresolved disorder model. using A ATOM 656 CB ALYS 80 -21.736 10.557 23.475 0.45 17.36 C Unresolved disorder model. using A ATOM 657 CG ALYS 80 -23.280 10.565 23.437 0.45 18.47 C Unresolved disorder model. using A ATOM 658 CD ALYS 80 -23.850 12.002 23.234 0.45 18.18 C Unresolved disorder model. using A ATOM 659 CE ALYS 80 -25.363 12.113 23.557 0.45 19.77 C Unresolved disorder model. using A ATOM 660 NZ ALYS 80 -25.945 13.499 23.337 0.45 19.11 N Unresolved disorder model. using A ATOM 661 CA BLYS 80 -21.165 9.208 23.559 0.55 16.90 C Unresolved disorder model. using A ATOM 662 CB BLYS 80 -22.232 10.281 23.425 0.55 17.32 C Unresolved disorder model. using A ATOM 663 CG BLYS 80 -22.072 11.202 22.271 0.55 17.07 C Unresolved disorder model. using A ATOM 664 CD BLYS 80 -23.212 12.145 22.218 0.55 18.28 C Unresolved disorder model. using A ATOM 665 CE BLYS 80 -22.893 13.319 21.363 0.55 21.54 C Unresolved disorder model. using A ATOM 666 NZ BLYS 80 -23.936 14.376 21.512 0.55 24.18 N Unresolved disorder model. using A ATOM 903 N ALYS 111 -7.827 -15.259 28.160 0.50 14.16 N Unresolved disorder model. using A ATOM 904 CA ALYS 111 -6.760 -15.775 27.296 0.50 14.59 C Unresolved disorder model. using A ATOM 905 C ALYS 111 -7.247 -16.340 25.968 0.50 14.38 C Unresolved disorder model. using A ATOM 906 O ALYS 111 -6.428 -16.723 25.126 0.50 15.38 O Unresolved disorder model. using A ATOM 907 CB ALYS 111 -5.834 -16.740 28.046 0.50 15.38 C Unresolved disorder model. using A ATOM 908 CG ALYS 111 -4.942 -16.034 29.058 0.50 17.29 C Unresolved disorder model. using A ATOM 909 CD ALYS 111 -3.782 -15.284 28.402 0.50 16.97 C Unresolved disorder model. using A ATOM 910 CE ALYS 111 -2.741 -14.886 29.432 0.50 15.46 C Unresolved disorder model. using A ATOM 911 NZ ALYS 111 -3.222 -13.771 30.236 0.50 17.32 N Unresolved disorder model. using A ATOM 912 N BLYS 111 -7.832 -15.279 28.136 0.50 14.07 N Unresolved disorder model. using A ATOM 913 CA BLYS 111 -6.759 -15.854 27.321 0.50 14.45 C Unresolved disorder model. using A ATOM 914 C BLYS 111 -7.249 -16.386 25.977 0.50 14.31 C Unresolved disorder model. using A ATOM 915 O BLYS 111 -6.441 -16.796 25.140 0.50 15.31 O Unresolved disorder model. using A ATOM 916 CB BLYS 111 -5.954 -16.899 28.113 0.50 15.27 C Unresolved disorder model. using A ATOM 917 CG BLYS 111 -5.450 -16.387 29.470 0.50 16.49 C Unresolved disorder model. using A ATOM 918 CD BLYS 111 -4.618 -15.076 29.334 0.50 16.28 C Unresolved disorder model. using A ATOM 919 CE BLYS 111 -3.896 -14.675 30.632 0.50 18.29 C Unresolved disorder model. using A ATOM 920 NZ BLYS 111 -2.483 -15.216 30.788 0.50 18.92 N Unresolved disorder model. using A ATOM 924 CA ALYS 112 -9.112 -16.741 24.467 0.45 13.60 C Unresolved disorder model. using A ATOM 925 CB ALYS 112 -10.616 -16.962 24.560 0.45 13.49 C Unresolved disorder model. using A ATOM 926 CG ALYS 112 -11.214 -17.471 23.280 0.45 14.12 C Unresolved disorder model. using A ATOM 927 CD ALYS 112 -12.726 -17.490 23.305 0.45 15.39 C Unresolved disorder model. using A ATOM 928 CE ALYS 112 -13.269 -17.940 21.970 0.45 16.13 C Unresolved disorder model. using A ATOM 929 NZ ALYS 112 -12.927 -16.979 20.890 0.45 19.67 N Unresolved disorder model. using A ATOM 930 CA BLYS 112 -9.141 -16.734 24.459 0.55 13.43 C Unresolved disorder model. using A ATOM 931 CB BLYS 112 -10.663 -16.913 24.541 0.55 13.24 C Unresolved disorder model. using A ATOM 932 CG BLYS 112 -11.366 -17.092 23.191 0.55 13.83 C Unresolved disorder model. using A ATOM 933 CD BLYS 112 -12.882 -17.336 23.346 0.55 15.05 C Unresolved disorder model. using A ATOM 934 CE BLYS 112 -13.546 -17.739 22.028 0.55 15.54 C Unresolved disorder model. using A ATOM 935 NZ BLYS 112 -12.953 -18.965 21.424 0.55 18.20 N Unresolved disorder model. using A ATOM 1236 CA ASER 152 -22.419 -17.766 9.847 0.50 18.16 C Unresolved disorder model. using A ATOM 1237 CB ASER 152 -23.843 -17.589 10.352 0.50 18.80 C Unresolved disorder model. using A ATOM 1238 OG ASER 152 -24.273 -18.735 11.060 0.50 21.99 O Unresolved disorder model. using A ATOM 1239 CA BSER 152 -22.427 -17.762 9.853 0.50 17.80 C Unresolved disorder model. using A ATOM 1240 CB BSER 152 -23.862 -17.589 10.358 0.50 18.33 C Unresolved disorder model. using A ATOM 1241 OG BSER 152 -23.981 -16.539 11.315 0.50 18.51 O Unresolved disorder model. using A ATOM 1284 N ALYS 159 -20.282 -6.093 1.719 0.50 17.83 N Unresolved disorder model. using A ATOM 1285 CA ALYS 159 -19.876 -4.939 0.904 0.50 17.95 C Unresolved disorder model. using A ATOM 1286 C ALYS 159 -18.384 -4.627 1.047 0.50 16.98 C Unresolved disorder model. using A ATOM 1287 O ALYS 159 -17.744 -4.190 0.103 0.50 17.52 O Unresolved disorder model. using A ATOM 1288 CB ALYS 159 -20.707 -3.701 1.254 0.50 18.37 C Unresolved disorder model. using A ATOM 1289 CG ALYS 159 -22.011 -3.599 0.477 0.50 19.50 C Unresolved disorder model. using A ATOM 1290 CD ALYS 159 -22.998 -2.621 1.134 0.50 19.95 C Unresolved disorder model. using A ATOM 1291 CE ALYS 159 -22.838 -1.205 0.634 0.50 20.29 C Unresolved disorder model. using A ATOM 1292 NZ ALYS 159 -23.942 -0.281 1.156 0.50 20.96 N Unresolved disorder model. using A ATOM 1293 N BLYS 159 -20.277 -6.098 1.715 0.50 17.52 N Unresolved disorder model. using A ATOM 1294 CA BLYS 159 -19.855 -4.982 0.883 0.50 17.43 C Unresolved disorder model. using A ATOM 1295 C BLYS 159 -18.353 -4.745 1.019 0.50 16.67 C Unresolved disorder model. using A ATOM 1296 O BLYS 159 -17.669 -4.516 0.035 0.50 17.12 O Unresolved disorder model. using A ATOM 1297 CB BLYS 159 -20.609 -3.719 1.246 0.50 17.68 C Unresolved disorder model. using A ATOM 1298 CG BLYS 159 -20.362 -2.587 0.269 0.50 17.39 C Unresolved disorder model. using A ATOM 1299 CD BLYS 159 -20.718 -1.285 0.885 0.50 18.28 C Unresolved disorder model. using A ATOM 1300 CE BLYS 159 -21.093 -0.265 -0.117 0.50 20.76 C Unresolved disorder model. using A ATOM 1301 NZ BLYS 159 -21.498 0.931 0.621 0.50 21.13 N Unresolved disorder model. using A ATOM 1361 N ALYS 168 -5.933 -4.775 -3.297 0.45 13.52 N Unresolved disorder model. using A ATOM 1362 CA ALYS 168 -5.051 -5.851 -2.857 0.45 13.80 C Unresolved disorder model. using A ATOM 1363 C ALYS 168 -3.784 -5.380 -2.159 0.45 13.80 C Unresolved disorder model. using A ATOM 1364 O ALYS 168 -3.393 -5.964 -1.145 0.45 14.47 O Unresolved disorder model. using A ATOM 1365 CB ALYS 168 -4.655 -6.767 -4.030 0.45 14.04 C Unresolved disorder model. using A ATOM 1366 CG ALYS 168 -3.673 -7.836 -3.607 0.45 13.88 C Unresolved disorder model. using A ATOM 1367 CD ALYS 168 -3.366 -8.845 -4.704 0.45 14.57 C Unresolved disorder model. using A ATOM 1368 CE ALYS 168 -3.152 -10.239 -4.105 0.45 14.97 C Unresolved disorder model. using A ATOM 1369 NZ ALYS 168 -2.908 -11.339 -5.116 0.45 15.81 N Unresolved disorder model. using A ATOM 1370 N BLYS 168 -5.915 -4.751 -3.303 0.55 13.51 N Unresolved disorder model. using A ATOM 1371 CA BLYS 168 -5.085 -5.843 -2.845 0.55 13.99 C Unresolved disorder model. using A ATOM 1372 C BLYS 168 -3.744 -5.450 -2.240 0.55 13.82 C Unresolved disorder model. using A ATOM 1373 O BLYS 168 -3.248 -6.181 -1.381 0.55 13.41 O Unresolved disorder model. using A ATOM 1374 CB BLYS 168 -4.847 -6.836 -3.984 0.55 14.43 C Unresolved disorder model. using A ATOM 1375 CG BLYS 168 -4.377 -8.164 -3.487 0.55 15.55 C Unresolved disorder model. using A ATOM 1376 CD BLYS 168 -4.199 -9.124 -4.658 0.55 15.46 C Unresolved disorder model. using A ATOM 1377 CE BLYS 168 -2.876 -8.868 -5.365 0.55 17.69 C Unresolved disorder model. using A ATOM 1378 NZ BLYS 168 -2.623 -9.909 -6.430 0.55 19.10 N Unresolved disorder model. using A ATOM 1389 CA ALYS 170 -0.377 -1.170 -0.191 0.50 15.22 C Unresolved disorder model. using A ATOM 1390 CB ALYS 170 1.009 -1.172 0.449 0.50 14.99 C Unresolved disorder model. using A ATOM 1391 CG ALYS 170 1.317 0.038 1.333 0.50 15.41 C Unresolved disorder model. using A ATOM 1392 CD ALYS 170 2.669 -0.147 2.039 0.50 16.79 C Unresolved disorder model. using A ATOM 1393 CE ALYS 170 3.109 1.069 2.838 0.50 18.33 C Unresolved disorder model. using A ATOM 1394 NZ ALYS 170 2.379 1.367 4.095 0.50 20.40 N Unresolved disorder model. using A ATOM 1395 CA BLYS 170 -0.333 -1.182 -0.207 0.50 15.01 C Unresolved disorder model. using A ATOM 1396 CB BLYS 170 1.103 -1.263 0.288 0.50 14.58 C Unresolved disorder model. using A ATOM 1397 CG BLYS 170 1.665 -0.014 0.905 0.50 15.10 C Unresolved disorder model. using A ATOM 1398 CD BLYS 170 2.961 -0.328 1.681 0.50 15.86 C Unresolved disorder model. using A ATOM 1399 CE BLYS 170 4.035 -0.954 0.808 0.50 17.87 C Unresolved disorder model. using A ATOM 1400 NZ BLYS 170 5.356 -1.054 1.522 0.50 19.31 N Unresolved disorder model. using A ATOM 1405 N ALYS 172 -3.234 1.171 -2.527 0.55 16.34 N Unresolved disorder model. using A ATOM 1406 CA ALYS 172 -4.448 1.159 -3.339 0.55 16.42 C Unresolved disorder model. using A ATOM 1407 C ALYS 172 -5.626 1.614 -2.491 0.55 16.41 C Unresolved disorder model. using A ATOM 1408 O ALYS 172 -5.734 1.274 -1.299 0.55 15.91 O Unresolved disorder model. using A ATOM 1409 CB ALYS 172 -4.759 -0.226 -3.952 0.55 16.66 C Unresolved disorder model. using A ATOM 1410 CG ALYS 172 -3.865 -0.623 -5.133 0.55 16.70 C Unresolved disorder model. using A ATOM 1411 CD ALYS 172 -4.407 -1.788 -5.979 0.55 17.35 C Unresolved disorder model. using A ATOM 1412 CE ALYS 172 -5.416 -1.339 -7.078 0.55 18.36 C Unresolved disorder model. using A ATOM 1413 NZ ALYS 172 -6.015 -2.466 -7.888 0.55 19.54 N Unresolved disorder model. using A ATOM 1414 N BLYS 172 -3.255 1.185 -2.486 0.45 16.42 N Unresolved disorder model. using A ATOM 1415 CA BLYS 172 -4.432 1.180 -3.329 0.45 16.35 C Unresolved disorder model. using A ATOM 1416 C BLYS 172 -5.654 1.566 -2.510 0.45 16.45 C Unresolved disorder model. using A ATOM 1417 O BLYS 172 -5.815 1.139 -1.356 0.45 16.00 O Unresolved disorder model. using A ATOM 1418 CB BLYS 172 -4.635 -0.188 -3.984 0.45 16.68 C Unresolved disorder model. using A ATOM 1419 CG BLYS 172 -3.512 -0.587 -4.934 0.45 16.52 C Unresolved disorder model. using A ATOM 1420 CD BLYS 172 -3.579 0.206 -6.243 0.45 17.79 C Unresolved disorder model. using A ATOM 1421 CE BLYS 172 -2.556 -0.275 -7.297 0.45 17.20 C Unresolved disorder model. using A ATOM 1422 NZ BLYS 172 -3.137 -0.243 -8.692 0.45 17.37 N Unresolved disorder model. using A ATOM 1798 CA ASER 220 -15.077 -18.791 6.563 0.50 15.99 C Unresolved disorder model. using A ATOM 1799 CB ASER 220 -14.914 -20.309 6.497 0.50 16.05 C Unresolved disorder model. using A ATOM 1800 OG ASER 220 -13.552 -20.643 6.621 0.50 16.68 O Unresolved disorder model. using A ATOM 1801 CA BSER 220 -15.076 -18.806 6.552 0.50 15.91 C Unresolved disorder model. using A ATOM 1802 CB BSER 220 -14.956 -20.325 6.435 0.50 15.94 C Unresolved disorder model. using A ATOM 1803 OG BSER 220 -16.020 -20.832 5.660 0.50 15.90 O Unresolved disorder model. using A ATOM 1825 CA AVAL 223 -12.422 -14.344 6.368 0.45 17.47 C Unresolved disorder model. using A ATOM 1826 CB AVAL 223 -12.248 -15.176 7.661 0.45 18.05 C Unresolved disorder model. using A ATOM 1827 CG1AVAL 223 -10.892 -14.850 8.342 0.45 17.71 C Unresolved disorder model. using A ATOM 1828 CG2AVAL 223 -13.380 -14.887 8.629 0.45 15.94 C Unresolved disorder model. using A ATOM 1829 CA BVAL 223 -12.430 -14.255 6.325 0.55 17.53 C Unresolved disorder model. using A ATOM 1830 CB BVAL 223 -12.232 -14.800 7.746 0.55 18.21 C Unresolved disorder model. using A ATOM 1831 CG1BVAL 223 -11.747 -16.251 7.724 0.55 18.03 C Unresolved disorder model. using A ATOM 1832 CG2BVAL 223 -11.238 -13.921 8.482 0.55 15.27 C Unresolved disorder model. using A ATOM 2095 N AGLN 255 -7.483 -1.014 35.846 0.45 17.51 N Unresolved disorder model. using A ATOM 2096 CA AGLN 255 -8.659 -1.724 36.273 0.45 16.77 C Unresolved disorder model. using A ATOM 2097 C AGLN 255 -9.626 -1.772 35.080 0.45 16.30 C Unresolved disorder model. using A ATOM 2098 O AGLN 255 -9.916 -0.742 34.460 0.45 16.49 O Unresolved disorder model. using A ATOM 2099 CB AGLN 255 -9.294 -1.005 37.466 0.45 17.39 C Unresolved disorder model. using A ATOM 2100 CG AGLN 255 -8.620 -1.285 38.807 0.45 17.60 C Unresolved disorder model. using A ATOM 2101 CD AGLN 255 -9.342 -2.367 39.584 0.45 19.05 C Unresolved disorder model. using A ATOM 2102 OE1AGLN 255 -10.035 -2.091 40.567 0.45 19.59 O Unresolved disorder model. using A ATOM 2103 NE2AGLN 255 -9.214 -3.604 39.123 0.45 20.95 N Unresolved disorder model. using A ATOM 2104 N BGLN 255 -7.481 -0.994 35.922 0.55 17.80 N Unresolved disorder model. using A ATOM 2105 CA BGLN 255 -8.655 -1.749 36.268 0.55 17.23 C Unresolved disorder model. using A ATOM 2106 C BGLN 255 -9.495 -1.815 34.979 0.55 16.33 C Unresolved disorder model. using A ATOM 2107 O BGLN 255 -9.529 -0.862 34.185 0.55 15.77 O Unresolved disorder model. using A ATOM 2108 CB BGLN 255 -9.470 -1.113 37.416 0.55 17.90 C Unresolved disorder model. using A ATOM 2109 CG BGLN 255 -8.788 -0.011 38.241 0.55 18.85 C Unresolved disorder model. using A ATOM 2110 CD BGLN 255 -9.767 0.691 39.171 0.55 19.75 C Unresolved disorder model. using A ATOM 2111 OE1BGLN 255 -9.912 1.929 39.158 0.55 21.48 O Unresolved disorder model. using A ATOM 2112 NE2BGLN 255 -10.465 -0.105 39.969 0.55 22.86 N Unresolved disorder model. using A ATOM 2124 CA ALYS 257 -14.668 -2.185 34.355 0.50 14.34 C Unresolved disorder model. using A ATOM 2125 CB ALYS 257 -15.006 -0.711 34.488 0.50 14.52 C Unresolved disorder model. using A ATOM 2126 CG ALYS 257 -14.038 0.083 35.347 0.50 16.34 C Unresolved disorder model. using A ATOM 2127 CD ALYS 257 -14.298 1.584 35.230 0.50 17.16 C Unresolved disorder model. using A ATOM 2128 CE ALYS 257 -13.420 2.376 36.179 0.50 19.16 C Unresolved disorder model. using A ATOM 2129 NZ ALYS 257 -13.386 3.835 35.849 0.50 19.76 N Unresolved disorder model. using A ATOM 2130 CA BLYS 257 -14.673 -2.200 34.354 0.50 13.92 C Unresolved disorder model. using A ATOM 2131 CB BLYS 257 -15.034 -0.732 34.524 0.50 14.19 C Unresolved disorder model. using A ATOM 2132 CG BLYS 257 -14.211 0.014 35.560 0.50 15.69 C Unresolved disorder model. using A ATOM 2133 CD BLYS 257 -14.021 -0.817 36.808 0.50 16.38 C Unresolved disorder model. using A ATOM 2134 CE BLYS 257 -13.477 -0.029 37.973 0.50 18.87 C Unresolved disorder model. using A ATOM 2135 NZ BLYS 257 -12.582 1.082 37.558 0.50 20.26 N 1